Peter H. Watson

Top papers

• The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

  METABRIC Group, Christina Curtis, Sohrab P. Shah, et al.·2012·Nature
  ↗ 6,318OA
• New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆

  Hans F. A. Vasen, Peter H. Watson, Jukka‐Pekka Mecklin, et al.·1999·Gastroenterology
  ↗ 2,502
• <i>Fusobacterium nucleatum</i> infection is prevalent in human colorectal carcinoma

  Mauro Castellarin, Robin M. Warren, Jamie Freeman, et al.·2011·Genome Research
  ↗ 2,034OA
• The clonal and mutational evolution spectrum of primary triple-negative breast cancers

  Sohrab P. Shah, Andrew Roth, Rodrigo Goya, et al.·2012·Nature
  ↗ 2,018
• Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

  Charles C. Wykoff, Nigel Beasley, Peter H. Watson, et al.·2000·PubMed
  ↗ 1,284
• Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

  Sohrab P. Shah, Ryan D. Morin, Jaswinder Khattra, et al.·2009·Nature
  ↗ 1,075OA
• Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

  Shona Hendry, Roberto Salgado, Thomas Gevaert, et al.·2017·Advances in Anatomic Pathology
  ↗ 795OA
• HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors.

  Heidi Sowter, Peter J. Ratcliffe, Peter H. Watson, et al.·2001·PubMed
  ↗ 717
• Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

  Shona Hendry, Roberto Salgado, Thomas Gevaert, et al.·2017·Advances in Anatomic Pathology
  ↗ 712OA
• CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer

  Julie S. Nielsen, Rob A. Sahota, Katy Milne, et al.·2012·Clinical Cancer Research
  ↗ 543
• Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

  Katy Milne, Martin Köbel, Steven E. Kalloger, et al.·2009·PLoS ONE
  ↗ 431OA
• Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma

  Stephen Chia, Charles C. Wykoff, Peter H. Watson, et al.·2001·Journal of Clinical Oncology
  ↗ 431